PMID- 27830498 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 2194-7791 (Print) IS - 2194-7791 (Electronic) IS - 2194-7791 (Linking) VI - 3 IP - 1 DP - 2016 Dec TI - Wilms' tumor susceptibility: possible involvement of FOXP3 and CXCL12 genes. PG - 36 LID - 36 AB - BACKGROUND: Wilms' tumor is an embryonal neoplasm of the kidney that accounts for approximately 6 % of all childhood tumors. The chemokine CXCL12 (C-X-C chemokine ligand 12) and its ligand CXCR4 (C-X-C chemokine receptor type 4) are involved in the development of several organs, including the kidney, and are also associated with tumor growth and metastasis. FOXP3 (forkhead transcription factor 3) was initially described as a marker for regulatory T cells; however, its expression in several types of tumor cells has already been described and may have prognostic significance. The aim of the present study was to analyze rs3761548 and rs2232365 FOXP3 polymorphisms, as well as evaluate rs1801157 CXCL12 polymorphism in Wilms' tumor samples. METHODS: Polymorphisms were evaluated in 32 patients and 78 neoplasia-free controls. Genotypes of rs1801157 were determined using PCR-restriction fragment length polymorphism (PCR-RFLP) method, and genotypes of rs2232365 and rs3761548 were determined using allele-specific PCR (AS-PCR). RESULTS: The case-control study indicated a significant association for allele A carriers of rs1801157 polymorphism in relation to Wilms' tumor susceptibility (OR = 5.261; 95 % CI 2.156 to 12.84; p = 0.0002). The opposite was observed in male carriers of G allele for rs2232365 polymorphism (OR 0.1164; 95 % CI 0.0227 to 0.5954; p = 0.0091) or when male and female subjects were analyzed (OR = 0.1304; 95 % CI 0.05013 to 0.3394; p < 0.0001). CONCLUSIONS: All in all, these markers may contribute to this neoplasia susceptibility and progression; however, further studies are needed to real clarify their role in Wilms' tumor pathogenesis. FAU - Ozawa, Patricia Midori Murobushi AU - Ozawa PM AD - Department of Pathological Sciences, Laboratory of Study and Application of DNA Polymorphisms, Biological Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Ariza, Carolina Batista AU - Ariza CB AD - Department of Pathological Sciences, Laboratory of Study and Application of DNA Polymorphisms, Biological Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Losi-Guembarovski, Roberta AU - Losi-Guembarovski R AD - Department of Pathological Sciences, Laboratory of Study and Application of DNA Polymorphisms, Biological Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Guembarovski, Alda Losi AU - Guembarovski AL AD - Department of Pathology, Clinical Analysis and Toxicology, Health Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - de Oliveira, Carlos Eduardo Coral AU - de Oliveira CE AD - Department of Pathological Sciences, Laboratory of Study and Application of DNA Polymorphisms, Biological Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Banin-Hirata, Bruna Karina AU - Banin-Hirata BK AD - Department of Pathological Sciences, Laboratory of Study and Application of DNA Polymorphisms, Biological Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Kishima, Marina Okuyama AU - Kishima MO AD - Department of Pathology, Clinical Analysis and Toxicology, Health Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Petenuci, Diego Lima AU - Petenuci DL AD - Department of Pathological Sciences, Laboratory of Study and Application of DNA Polymorphisms, Biological Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Watanabe, Maria Angelica Ehara AU - Watanabe MA AD - Department of Pathological Sciences, Laboratory of Study and Application of DNA Polymorphisms, Biological Sciences Center, State University of Londrina, Londrina, PR, Brazil. maewatuel@gmail.com. LA - eng PT - Journal Article DEP - 20161110 PL - Germany TA - Mol Cell Pediatr JT - Molecular and cellular pediatrics JID - 101660689 PMC - PMC5103003 OTO - NOTNLM OT - CXCL12 OT - FOXP3 OT - Genetic polymorphism OT - Wilms' tumor EDAT- 2016/11/11 06:00 MHDA- 2016/11/11 06:01 PMCR- 2016/11/10 CRDT- 2016/11/11 06:00 PHST- 2016/08/08 00:00 [received] PHST- 2016/10/18 00:00 [accepted] PHST- 2016/11/11 06:00 [entrez] PHST- 2016/11/11 06:00 [pubmed] PHST- 2016/11/11 06:01 [medline] PHST- 2016/11/10 00:00 [pmc-release] AID - 10.1186/s40348-016-0064-4 [pii] AID - 64 [pii] AID - 10.1186/s40348-016-0064-4 [doi] PST - ppublish SO - Mol Cell Pediatr. 2016 Dec;3(1):36. doi: 10.1186/s40348-016-0064-4. Epub 2016 Nov 10.